STAP1 and hepatocellular carcinoma: In summary, STAP1 provides proof of principle for potential DNA methylation biomarkers in HCC peripheral white blood cells and for discriminating Stage 1 from chronic hepatitis and healthy controls which is a critical hurdle in early diagnosis of liver cancer.